Cite
APA Citation
Bradley, J. S., Makieieva, N., Tøndel, C., Roilides, E., Kelly, M. S., Patel, M., Vaddady, P., Maniar, A., Zhang, Y., Paschke, A., Butterton, J. R., & Chen, L. F. (n.d.). 1159. Pharmacokinetics, Safety, and Tolerability of Imipenem/Cilastatin/Relebactam in Pediatric Participants With Confirmed or Suspected Gram-negative Bacterial Infections: A Phase 1b, Open-label, Single-Dose Clinical Trial. Open forum infectious diseases, 8, S671. http://access.bl.uk/ark:/81055/vdc_100150542722.0x000036